Fawwad Qureshi Sells 622 Shares of Trupanion, Inc. (NASDAQ:TRUP) Stock

Trupanion, Inc. (NASDAQ:TRUP) CFO Fawwad Qureshi sold 622 shares of Trupanion stock in a transaction dated Tuesday, November 26th. The stock was sold at an average price of $52.61, for a total transaction of $32,723.42. Following the sale, the chief financial officer now directly owns 9,867 shares of the company’s stock, valued at $519,102.87. The trade was a 5.93 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink.

Trupanion Price Performance

TRUP stock opened at $53.50 on Friday. The stock has a market cap of $2.27 billion, a price-to-earnings ratio of -167.19 and a beta of 1.69. The company has a debt-to-equity ratio of 0.40, a current ratio of 1.66 and a quick ratio of 1.66. The company has a 50 day simple moving average of $49.73 and a 200 day simple moving average of $40.06. Trupanion, Inc. has a 1 year low of $19.69 and a 1 year high of $57.90.

Trupanion (NASDAQ:TRUP) last announced its quarterly earnings results on Wednesday, October 30th. The financial services provider reported $0.03 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.06) by $0.09. Trupanion had a negative net margin of 1.08% and a negative return on equity of 4.36%. The company had revenue of $327.50 million during the quarter, compared to the consensus estimate of $321.79 million. During the same period in the prior year, the business earned ($0.10) earnings per share. The company’s revenue for the quarter was up 14.6% compared to the same quarter last year. Research analysts anticipate that Trupanion, Inc. will post -0.23 EPS for the current fiscal year.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the business. Vanguard Group Inc. raised its position in Trupanion by 0.9% during the 1st quarter. Vanguard Group Inc. now owns 3,673,791 shares of the financial services provider’s stock worth $101,433,000 after purchasing an additional 32,485 shares during the last quarter. Wellington Management Group LLP increased its position in Trupanion by 4.4% during the 3rd quarter. Wellington Management Group LLP now owns 3,393,879 shares of the financial services provider’s stock valued at $142,475,000 after purchasing an additional 142,156 shares during the period. FMR LLC lifted its position in shares of Trupanion by 55,963.7% in the 3rd quarter. FMR LLC now owns 1,172,293 shares of the financial services provider’s stock worth $49,213,000 after purchasing an additional 1,170,202 shares during the period. Marshall Wace LLP boosted its stake in shares of Trupanion by 11.9% in the 2nd quarter. Marshall Wace LLP now owns 1,094,589 shares of the financial services provider’s stock valued at $32,181,000 after purchasing an additional 116,496 shares during the last quarter. Finally, DF Dent & Co. Inc. boosted its stake in shares of Trupanion by 27.8% in the 3rd quarter. DF Dent & Co. Inc. now owns 367,871 shares of the financial services provider’s stock valued at $15,443,000 after purchasing an additional 80,014 shares during the last quarter.

Analyst Upgrades and Downgrades

A number of brokerages have recently weighed in on TRUP. Bank of America increased their target price on Trupanion from $47.00 to $56.00 and gave the stock a “buy” rating in a research note on Friday, September 20th. Piper Sandler increased their price objective on Trupanion from $45.00 to $57.00 and gave the stock a “neutral” rating in a research report on Thursday, October 31st. Evercore ISI raised shares of Trupanion to a “strong-buy” rating in a research report on Friday, August 9th. Northland Securities lifted their price objective on shares of Trupanion from $45.00 to $50.00 and gave the stock a “market perform” rating in a research note on Thursday, October 31st. Finally, Stifel Nicolaus increased their target price on shares of Trupanion from $30.00 to $40.00 and gave the stock a “hold” rating in a research report on Monday, September 23rd. Three equities research analysts have rated the stock with a hold rating, three have given a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, Trupanion presently has an average rating of “Moderate Buy” and a consensus price target of $44.67.

Trupanion Company Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.